Genpact Limited

Valuation Analysis

About the Company

Genpact Limited en bref

Genpact Limited (G) is currently trading at 24,65 € with a market capitalization of 4,2 Md €. The trailing P/E ratio stands at 8.67x, with a forward P/E of 6.31x. The 52-week range spans from 23,91 € to 42,45 €; the current price is 41.9% below the yearly high. Year-over-year revenue growth stands at +6.7%. The net profit margin stands at 11.04%.

💰 Dividende

Genpact Limited pays an annual dividend of 0,65 € per share, representing a yield of 2.65%. The payout ratio stands at 21.4%.

📊 Avis des analystes

11 analystes évaluent Genpact Limited (G) au consensus : None. L'objectif de cours moyen est de 37,05 €, soit un potentiel de +50.28% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 27,93 € à 50,62 €.

Genpact Limited : la thèse d'investissement en détail

Genpact Limited (G) operates in the Technology — specifically Information Technology Services — and is headquartered in Bermuda. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

Le scénario baissier

Short interest sits at 12.46% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

Valorisation en contexte

The PEG ratio at 1.16 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric. The EV/EBITDA multiple of 7.1x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

À surveiller

• The forward P/E of 6.31x is meaningfully below the trailing 8.67x — analysts expect earnings to step up; the next earnings release is the test.
• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 50.28% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

The data points to relatively defensive market behavior, elevated short interest (12.46%).

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Genpact Limited?

Compare top-rated brokers — low fees, trusted providers, fully regulated.